Overview

A Study to Assess the Pharmacokinetics of AZD6793 When Administered Alone and in Combination With Itraconazole in Healthy Participants.

Status:
COMPLETED

Trial end date:
2024-10-05

Target enrollment:

Participant gender:

Summary

The study will evaluate the pharmacokinetics (PK) of AZD6793 when administered alone and in combination with itraconazole in healthy adult participants.

Phase:

PHASE1

Details

Lead Sponsor:

AstraZeneca

Treatments:

Itraconazole